[1]
Türker EGESEL et al. 2019. Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein. Turkish Journal of Gastroenterology. 13, 2 (Jul. 2019), 89–93.